Therefore, understanding how ZIKV interacts with the INF system and influences the outcome of infection in barrier tissues such as the placenta, eyes and brain during pregnancy may help in the development of therapeutic strategies to clear ZIKV from the organism, based on the action mechanism of the IFN system, and keeping immune-privileged organs safe during both fetal development and in adults. The gene discussed is IFNA1; the disease is infection.